This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More
Anacor Pharmaceuticals Inc
ANAC : NASDAQ : Health Care
$32.23 | %
Today's Range: 31.40 - 32.50
Avg. Daily Volume: 559,400
11/21/14 - 3:59 PM ET

PEER GROUP: Biotechnology

Ticker Company Name Recent
Net Sales
Net Income
ANAC ANACOR PHARMACEUTICALS INC 31.46 1349.54 26.66 19.53 62.32
OPHT OPHTHOTECH CORP 42.60 1433.53 n/m 39.58 n/a
KERX KERYX BIOPHARMACEUTICALS INC 15.48 1423.23 n/m 10.26 46.51
ACOR ACORDA THERAPEUTICS INC 33.73 1414.91 60.23 376.20 15.64
PTCT PTC THERAPEUTICS INC 41.19 1384.11 n/m 17.00 -26.56
INSY INSYS THERAPEUTICS INC 38.71 1353.22 26.64 195.81 204.76
PTLA PORTOLA PHARMACEUTICALS INC 26.67 1297.02 n/m 9.27 72.75
CLDX CELLDEX THERAPEUTICS INC 14.26 1277.54 n/m 2.73 -61.77
PDLI PDL BIOPHARMA INC 7.89 1267.56 4.03 465.73 11.19
NVAX NOVAVAX INC 5.19 1237.70 n/m 32.68 95.32
CMRX CHIMERIX INC 32.92 1200.76 n/m 3.76 7.79
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

ANAC Ind Avg S&P 500
26.66 61.84 19.78

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades

Top Rated Stocks Top Rated Funds Top Rated ETFs